Acute hepatitis C: Changing epidemiology and association with HIV infection

Journal of HIV Therapy

Volumn 12, Issue 1, 2007, Pages 3-6

  Brejt, Nick ^b   Gilleece, Yvonne ^b   Fisher, Martin ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; DISEASE TRANSMISSION; FOLLOW UP; HEPATITIS C; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; REVIEW; RISK FACTOR;

ACUTE DISEASE; FOLLOW-UP STUDIES; HEPATITIS C; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; RISK FACTORS;

EID: 46449110104     PISSN: 14620308     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Rockstroh JK, Mocroft A, Soriano V et al. for the EuroSIDA study group. Influence of hepatitis C on HIV disease progression and response to antiretroviral therapy. J Infect Dis, 2005, 192, 992-1002.
2. Darby SC, Ewart DW, Giangrande PL et al. Mortality from liver cancer and liver disease in haemophiliac men and boys in the UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors Organisation. Lancet, 1997, 350, 1425-1431.
3. Lesens O, Deshenes M, Steben M et al. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive haemophiliacs and should be treated as an opportunistic infection. J Infect Dis, 1999, 79, 1254-1258.
4. Luetkemeyer A, Bradley Hare C, Stansell J et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients J Acquir Immune Defic Syndr, 2006, 41, 31-36.
5. Greub G, Ledergerber B, Battegay M, Grob P et al. Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet, 2000, 356, 1800-1805.
6. Mocroft A, Ledergerber B, Katlama C et al. Decline in AIDS and death rates in the EuroSIDA study: an observational study. Lancet, 2003, 362, 22-29.
7. Backus LI, Phillips BR, Boothroyd DB et al. Effects of hepatitis C virus co-infection on survival in veterans with HIV treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr, 2005, 39, 613-619.
8. Judd A, Hickman M, Jones S, Mcdonal T et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. Br Med J, 2005, 330, 24-25.
9. Health Protection Agency. Shooting Up - Infections among injecting drug users in the United Kingdom 2005, an update: October 2006.
10. Rooney G, Gilson R. Sexual transmission of hepatitis C virus infection. Sex Transm Infect, 1998, 74, 399-404.
11. Coutinho R and van de Laar T. Rise in HCV incidence in HIV-infected men who have sex with men in Amsterdam: sexual transmission of difficult to treat HCV genotypes 1 and 4. 13th Conference on Retroviruses and Opportunistic Infections, Denver, Co, USA, February 2006, Abstr. 87.
12. Ghosn J, Deveau C, Goujard C et al. Increase in hepatitis C virus incidence in HIV-1 infected patients followed up since primary infection. Sex Transm Infect, 2006, 82, 458-460.
13. Browne R, Asboe D, Gilleece Y et al. Increased numbers of acute hepatitis C infections in HIV positive homosexual men, is sexual transmission feeding the increase? Sex Transm Infect, 2004, 80, 326-327.
14. Rauch A, Rickenbach M, Weber R et al. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis, 2005, 41, 395-402.
15. Cohen DE, Russell CJ, Golub SA, Mayer KH. Prevalence of hepatitis C virus infection among men who have sex with men at a Boston Community Health Centre and its association with markers of high-risk behaviour. AIDS Patient Care and STDs, 2006, 20, 557-564.
16. Danta M, Brown D, Dusheiko G et al. Evidence for sexual transmission of HCV in recent epidemic in HIV-infected men in the UK. Sexual transmission of difficult to treat HCV genotypes 1 and 4. 13th Conference on Retroviruses and Opportunistic Infections, Denver, Co, USA, February 2006, Abstr. 86.
17. Turner J, Rider A, Imrie J et al. Behavioural predictors of subsequent hepatitis C diagnosis in a UK clinic sample of HIV positive men who have sex with men. Sex Transm Infect, 2006, 82, 298-300.
18. Gotz HM, van Doornum G, Niesters HG et al. A cluster of acute hepatitis C virus among men who have sex with men: results from contact tracing and public health implications. AIDS, 2005, 19, 969-974.
19. Marx MA, Murugavel KG, Tarwater PM et al. Association of hepatitis C virus infection with sexual exposure in southern India. Clin Infect Dis, 2003, 37, 514-520.
20. Mittal A. High frequency of antibodies to syphilis and HIV in hepatitis C virus positive blood donors may reflect its sexual transmission in this region. Sex Transm Infect, 2003, 79, 170-171.
21. Gambotti L, Batisse D, Colin-de-Verdiere N et al. Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Euro Surveill, 2005, 10, 115-117.
22. Gilleece Y, Browne R, Asboe D et al. Transmission of Hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavarin. J Acquir Immune Defic Syndr, 2005, 40, 41-46.
23. Vogel M, Bieniek B, Jessen H et al. Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases. J Viral Hepat, 2005, 12, 207-211.
24. Filippini P, Coppola N, Scolastico C et al. Does HIV infection favour the sexual transmission of Hepatitis C? Sex Transm Infect, 2001, 28, 725-729.
25. Fisher M, Richardson D, Sabin C. Acute hepatitis C in men who have sex with men is not confined to those infected with HIV and their number continues to increase. 14th Conference of Retroviruses and Opportunistic infections, Los Angeles, Ca, USA, February 2007, Abstr. 130.
26. Elford J. Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy. Curr Opin Infect Dis, 2006, 19, 26-32.
27. Elford J, Bolding G, Sherr L, Hart G. No evidence of increase in serosorting with casual partners among HIV-negative gay men in London, 1998-2005. AIDS, 2007, 21, 243-245.
28. Xia Q, Molitor F, Osmond DH et al. Knowledge of sexual partners' HIV status and serosorting practices in a California population-based sample of men who have sex with men. AIDS, 2006, 20, 2081-2089.
29. Serpaggi J, Chaix M-L, Batisse D et al. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1 infected men and inefficiency of early antiviral therapy. AIDS, 2006, 20, 233-240.
30. Fisher M, Barrett S, Sabin C et al. Increasing bacterial sexually transmitted infections in HIV positive men who have sex with men. 2nd IAS Conference on HIV Pathogenesis and Treatment, Paris, France, 13-16 July, 2003, Abstr. 998.
31. Briat A, Dulioust E, Galimand J et al. Hepatitis C virus in the semen of men co-infected with HIV-1: prevalence and origin. AIDS, 2005, 19, 1827-1835.
32. Bonacini M, Lin HJ, Hollinger FB. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune Defic Syndr, 2001, 26, 340-344.
33. Berggren R. False negative hepatitis C antibody is associated with low CD4 cell counts in HIV/HCV co-infected patients. 8th Conference on Retroviruses and Opportunistic Infections, Chicago, Il, USA, 4-8 February, 2001, Abstr 561.
34. Gerlach JT, Diepolder HM, Zachoval R et al. Acute hepatitis C: high rate of both spontaneous and treatment induced viral clearance. Gastroenterology, 2003, 125, 80-88.
35. Thomas DL, Astemborski J, Rai RM et al. The natural history of hepatitis C virus infection: host, viral and environmental factors. J Am Med Assoc, 2000, 284, 450-456.
36. Jauncey M, Micalef JM, Gilmour S et al. Clearance of hepatitis C virus after newly acquired infection in drug users. J Infect Dis, 2004, 190, 1270-1274.
37. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med, 1999, 340, 1228-1233.
38. Muller R. The natural history of hepatitis C: clinical experiences. J Hepatol, 1996, 24(Suppl), 52-54.
39. Bhagani S, Danta M, Huj C et al. Acute hepatitis C virus in a cohort of HIV positive men: outcomes and response to pegylated interferon-alfa 2b (PEG-IFN-alfa 2b) and ribavarin. 10th Anniversary Conference of the British HIV Association, Cardiff, UK, 15-17 April, 2004, Abstr. 020.
40. Santantonio T, Fasano M, Sinisi E et al. Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. J Hepatol, 2005, 42, 329-333.
41. Jaeckel E, Cornberg M,Wedemeyer H et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med, 2001, 345, 1452-1457.
42. Dominguez S, Ghosh J, Valantin M et al. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavarin in HIV-infected patients. AIDS, 2006, 20, 1157-1161.
43. Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet, 2001, 358, 958-965.
44. Torriani FJ, Rodriguez-Torres M, Rockstroh JK et al. Peginterferon-alfa- 2a plus ribavarin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med, 2004, 351, 438-450.
45. Carrat F, Bani-Sadr F, Pol S et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavarin for chronic hepatitis C in HIV-infected patients, a randomised controlled trial. J Am Med Assoc, 2004, 292, 2839-2848.
46. Chung RT, Anderson J, Volberding P et al. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med, 2004, 351, 451-459.